Oncolytic viruses are generally considered safe. While the concept may seem risky, these viruses are engineered to exclusively attack cancerous cells, leaving healthy tissue unharmed. Through careful manipulation in the lab, scientists have developed a method to program these viruses to specifically target cells with genetic markers associated with the patient's specific type of cancer.
This cutting-edge therapy offers new hope for patients battling cancer, providing a targeted and potentially more effective treatment option. By harnessing the power of these modified viruses, oncologists can deliver a precise attack on tumor cells while minimizing damage to surrounding healthy tissue.
Common side effects associated with the currently approved oncolytic virus may include but are not limited to: chills, fatigue, flu-like symptoms, injection site pain, nausea, and fever.
25 фев 2024